Glanbia plc (LON:GLB – Get Free Report) insider Thomas Phelan purchased 1,558 shares of Glanbia stock in a transaction dated Monday, May 12th. The stock was acquired at an average cost of GBX 1,151 ($15.32) per share, with a total value of £17,932.58 ($23,865.56).
Glanbia Stock Up 8.1%
GLB opened at GBX 11.78 ($0.16) on Wednesday. The company has a debt-to-equity ratio of 48.90, a current ratio of 1.63 and a quick ratio of 0.86. The business has a 50 day simple moving average of GBX 10.50 and a 200-day simple moving average of GBX 12.78. The stock has a market capitalization of £3.00 billion, a P/E ratio of 23.38, a P/E/G ratio of 8.32 and a beta of 0.47. Glanbia plc has a 12 month low of GBX 9.10 ($0.12) and a 12 month high of GBX 19.62 ($0.26).
Glanbia Increases Dividend
The firm also recently declared a dividend, which was paid on Friday, May 2nd. Stockholders of record on Thursday, March 20th were issued a €0.23 ($0.26) dividend. This is a boost from Glanbia’s previous dividend of $0.16. This represents a dividend yield of 2.18%. The ex-dividend date of this dividend was Thursday, March 20th. Glanbia’s dividend payout ratio (DPR) is currently 7,340.94%.
Glanbia Company Profile
We are a better nutrition company, home to consumer brands and ingredients that help people around the world feel strong, nourished, and to perform well at any age. Everything we do has real nutritional benefit. Everything we do is in pursuit of better, for each other and the planet.
Recommended Stories
- Five stocks we like better than Glanbia
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- NVIDIA Stock Surges on Bullish News: How High Could It Climb?
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Why Boeing May Be Ready to Take Off After Latest Developments
- Best Energy Stocks – Energy Stocks to Buy Now
- eBay Nears Big Breakout: Time to Buy the Under-the-Radar Winner?
Receive News & Ratings for Glanbia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Glanbia and related companies with MarketBeat.com's FREE daily email newsletter.